Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J K Rockstroh

Showing results (11-20 of 162) with videos related to

Pageof 17
Sort By:
The Journal of Antimicrobial Chemotherapy|August 24, 2005
HCV/HIV-coinfection--is there a state of the art after APRICOT and RIBAVIC?S Mauss, J K Rockstroh
HIV Medicine|June 17, 2020
COVID-19 research: an opinion pieceL Waters, J K Rockstroh
European Journal of Medical Research|July 20, 2004
Therapy of hepatitis C in HIV-coinfectionJ K Rockstroh, M Vogel
Der Internist|September 6, 2012
[Advances in management of HIV infections]M Battegay, J K Rockstroh
MMW Fortschritte Der Medizin|January 3, 2006
[Therapy of hepatitis B and hepatitis C coinfection in HIV patients]M Vogel, J K Rockstroh
Deutsche Medizinische Wochenschrift (1946)|January 27, 2006
[HIV and hepatitis coinfection]P Ingiliz, J K Rockstroh
Annals of Hematology|January 20, 1998
Pathogenesis and pathophysiology of anemia in HIV infectionK A Kreuzer, J K Rockstroh
Deutsche Medizinische Wochenschrift (1946)|March 23, 2007
[HIV-infection]J-C Wasmuth, J K Rockstroh
Cardiovascular Drugs and Therapy|December 1, 1990
When is discontinuation of antihypertensive therapy indicated?R E Schmieder, J K Rockstroh
European Journal of Medical Research|October 16, 2007
CCR5 antagonists: comparison of efficacy, side effects, pharmacokinetics and interactions--review of the literatureJ M Emmelkamp, J K Rockstroh
Pageof 17

Showing results (11-20 of 162) with videos related to

Sort By:
Pageof 17
The Journal of Antimicrobial Chemotherapy|August 24, 2005
HCV/HIV-coinfection--is there a state of the art after APRICOT and RIBAVIC?S Mauss, J K Rockstroh
HIV Medicine|June 17, 2020
COVID-19 research: an opinion pieceL Waters, J K Rockstroh
European Journal of Medical Research|July 20, 2004
Therapy of hepatitis C in HIV-coinfectionJ K Rockstroh, M Vogel
Der Internist|September 6, 2012
[Advances in management of HIV infections]M Battegay, J K Rockstroh
MMW Fortschritte Der Medizin|January 3, 2006
[Therapy of hepatitis B and hepatitis C coinfection in HIV patients]M Vogel, J K Rockstroh
Deutsche Medizinische Wochenschrift (1946)|January 27, 2006
[HIV and hepatitis coinfection]P Ingiliz, J K Rockstroh
Annals of Hematology|January 20, 1998
Pathogenesis and pathophysiology of anemia in HIV infectionK A Kreuzer, J K Rockstroh
Deutsche Medizinische Wochenschrift (1946)|March 23, 2007
[HIV-infection]J-C Wasmuth, J K Rockstroh
Cardiovascular Drugs and Therapy|December 1, 1990
When is discontinuation of antihypertensive therapy indicated?R E Schmieder, J K Rockstroh
European Journal of Medical Research|October 16, 2007
CCR5 antagonists: comparison of efficacy, side effects, pharmacokinetics and interactions--review of the literatureJ M Emmelkamp, J K Rockstroh
Pageof 17